BerGenBio ASA (BGBIO.OL)

NOK 1.67

(-2.0%)

Revenue Summary of BerGenBio ASA

BerGenBio ASA's latest annual revenue in 2023 was 354 Thousand NOK , down -9.0% from previous year.
BerGenBio ASA's latest quarterly revenue in 2024 Q2 was - NOK , down -100.0% from previous quarter.
BerGenBio ASA reported a annual revenue of 389 Thousand NOK in annual revenue 2022, down -49.74% from previous year.
BerGenBio ASA reported a annual revenue of 774 Thousand NOK in annual revenue 2021, up 28.79% from previous year.
BerGenBio ASA reported a quarterly revenue of - NOK for 2024 Q2, down -100.0% from previous quarter.
BerGenBio ASA reported a quarterly revenue of - NOK for 2023 Q3, down 0.0% from previous quarter.

Annual Revenue Chart of BerGenBio ASA (2023 - 2014)

Historical Annual Revenue of BerGenBio ASA (2023 - 2014)

Year	Revenue	Revenue Growth
2023	354 Thousand NOK	-9.0%
2022	389 Thousand NOK	-49.74%
2021	774 Thousand NOK	28.79%
2020	601 Thousand NOK	-93.25%
2019	8.9 Million NOK	281.16%
2018	2.33 Million NOK	0.0%
2017	- NOK	0.0%
2016	- NOK	0.0%
2015	- NOK	-100.0%
2014	598 Thousand NOK	0.0%

Year	Revenue	Revenue Growth
2024 Q1	167 Thousand NOK	-52.82%
2024 Q2	- NOK	-100.0%
2023 Q3	- NOK	0.0%
2023 Q2	- NOK	0.0%
2023 FY	354 Thousand NOK	-9.0%
2023 Q1	- NOK	-100.0%
2023 Q4	354 Thousand NOK	0.0%
2022 Q1	- NOK	-100.0%
2022 FY	389 Thousand NOK	-49.74%
2022 Q4	389 Thousand NOK	0.0%
2022 Q3	- NOK	0.0%
2022 Q2	- NOK	0.0%
2021 Q2	- NOK	0.0%
2021 Q3	- NOK	0.0%
2021 Q4	774 Thousand NOK	0.0%
2021 Q1	- NOK	-100.0%
2021 FY	774 Thousand NOK	28.79%
2020 Q3	- NOK	0.0%
2020 Q4	601 Thousand NOK	0.0%
2020 FY	601 Thousand NOK	-93.25%
2020 Q1	- NOK	-100.0%
2020 Q2	- NOK	0.0%
2019 Q3	- NOK	0.0%
2019 FY	8.9 Million NOK	281.16%
2019 Q4	218 Thousand NOK	0.0%
2019 Q2	- NOK	-100.0%
2019 Q1	8.68 Million NOK	271.82%
2018 Q3	- NOK	0.0%
2018 Q4	2.33 Million NOK	0.0%
2018 Q2	- NOK	0.0%
2018 FY	2.33 Million NOK	0.0%
2018 Q1	- NOK	0.0%
2017 Q2	- NOK	0.0%
2017 Q1	- NOK	0.0%
2017 FY	- NOK	0.0%
2017 Q3	- NOK	0.0%
2017 Q4	- NOK	0.0%
2016 FY	- NOK	0.0%
2016 Q3	- NOK	0.0%
2016 Q2	- NOK	0.0%
2016 Q4	- NOK	0.0%
2015 FY	- NOK	-100.0%
2014 FY	598 Thousand NOK	0.0%

Peer Revenue Comparison of BerGenBio ASA

Name	Revenue	Revenue Difference
Arctic Bioscience AS	33.75 Million NOK	98.951%
Aqua Bio Technology ASA	1.55 Million NOK	77.303%
ArcticZymes Technologies ASA	118.93 Million NOK	99.702%
Hofseth BioCare ASA	194.87 Million NOK	99.818%
PCI Biotech Holding ASA	2.99 Million NOK	88.161%
Thor Medical ASA	- NOK	-Infinity%
Ultimovacs ASA	- NOK	-Infinity%